The 5th National Research and Development Conference (NRDC) is set to feature some of the latest advancements and breakthrough technologies in health that were supported by the Department of Science and Technology – Philippine Council for Health Research and Development (DOST-PCHRD) in a virtual event on 9-11 November 2020.
With the theme, “Research and Development: Making Change Happen,” the 5th NRDC aims to bring together researchers, technology adopters, and industry leaders and present to them the latest technologies supported by DOST and other agencies, especially those that have impacted the government’s response against COVID-19. The different DOST Council heads will also be presenting updates on the Harmonized National R&D Agenda during the event.
Technologies and programs that will be featured under the health sector are:
GenAmplify Corona Virus 2019 (COVID-19) rRT PCR Detection Kit
Developed by Dr. Raul Destura from the University of the Philippines Manila – National Institutes of Health (UP – NIH), this diagnostic kit was locally developed to detect the 2019 novel coronavirus (SARS-CoV-2) with high specificity and efficiency through a one-step multiplex real-time polymerase chain reaction (PCR) platform. Priced significantly cheaper than its foreign counterparts, it provides accessible and affordable COVID-19 testing for Filipinos and expedited the process and turnaround period for COVID-19 testing in the Philippines.
Feasibility Analysis of Syndromic Surveillance using Spatio-Temporal Epidemiological Modeler
Designed and developed by researchers from the Ateneo Center for Computing Competency and Research (ACCCRe), in collaboration with the University of the Philippines Manila - National Telehealth Center (UPM-NTHC) and the Department of Health – Epidemiology Bureau (DOH-EB), FASSSTER is a web-based disease surveillance platform that uses deterministic compartmental modelling to facilitate understanding of the effect of specific interventions to the spread of diseases. Relative to the pandemic, the Department of Health (DOH) officially adopted FASSSTER as the national data hub to support real-time decision-making for the COVID-19 crisis.
SOLIDARITY Treatment Trial: Multicenter Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients
A global collaborative effort on the effectivity of repurposed antivirals in supporting the recovery of people who contracted COVID-19. This may be adopted in the official management protocol of COVID-19 patients, especially those who are critically ill.
In Vitro Study on the Efficacy of Lauric Acid and Deliverables Against SARS-CoV2
Led by Dr. Fabian Dayrit of the Ateneo de Manila University, the study aims to investigate whether coconut oil compounds, monolaurin and lauric acid, can be used as antiviral agents against COVID-19. Based on previous studies, these compounds are effective at killing viruses.
Tuklas Lunas Program: Drug Discovery and Development from Philippine Biodiversity
Recognizing the potential of the country’s natural resources for the discovery of novel drug compounds and local expertise in drug development, the DOST-PCHRD established the Tuklas Lunas Program. The priority conditions to be addressed includes cardiovascular diseases, cancers, and diabetes mellitus, and important communicable diseases such as tuberculosis and drug-resistant infections.
Tuklas Lunas Development Center: Mushroom Technologies
This research program on myko-mining and myko-pharming, headed by Dr. Renato G. Reyes from Central Luzon State University, works on the discovery and study of wild edible and poisonous mushrooms in Luzon Island, Philippines for their medicinal properties, and to develop functional food products from prioritized species of mushrooms. To date, the program was able to produce mushroom-based chips and shing-a-ling, generation of three bioactive extracts, and optimization of cultivation processes for priority mushroom species.
Improving Neurocognition through Dance and Kinesthetics (INDAK)
Headed by Dr. Jaqueline Dominguez and implemented by the Institute of Neurosciences of the St. Luke’s Medical Center -Quezon City, the INDAK program embraces the ability of dance, specifically ballroom dancing, to stimulate cognition, and physical and social activity. Currently, INDAK is conducted as an individualized home-based program, or facility-based program at the Institute for Dementia Care Asia, for elderly with mild cognitive impairment.
The 5th NRDC is hosted by the DOST in collaboration with the Commission on Higher Education (CHED), Department of Agriculture (DA), Department of Environment and Natural Resources (DENR), Department of Information and Communications Technology (DICT) and Department of Trade and Industry (DTI).
UN Secretary-General António Guterres appointed Dr. Jaime C. Montoya, Executive Director of the Department of Science and Technology - Philippine Council for Health Research and Development (DOST-PCHRD) as one of the 15 eminent scientists to draft the 2023 Global Sustainable Development Report (GSDR) in a UN official announcement yesterday in New York City.
Produced once every four yers, the SDG report aims to employ the scientific perspective in guiding policymakers on the state of global sustainable development, and serve as a ‘strong evidence-based instrument’ in eradicating poverty. The said report will also feed the ‘high-level global review” of the 2030 Agenda at the United Nations in September 2030.
The designation of the independent group followed an extensive consultation process that involved nominations from UN member states which concluded in December 2019. The 15 scientists were selected by UN Sec-Gen Guterres to author the GSDR and conduct a follow-up and review of the 2030 Agenda for SDGs.

“We are honored to be selected as part of the distinguished experts to author a very significant report on the global SDGs. Being a health research scientist in the Philippines, a developing country, enables us to contribute unique and substantial information that is relevant to sustainable development. It is without a doubt that I assure our UN member states and our fellow Filipinos that our efforts will always be directed towards the benefit of all through science and technology,” said Dr. Montoya.
The “diverse group,” according to the UN, represents a wide range of disciplines and are composed of the following scientists: John Agard (Trinidad and Tobago), Kaltham Ali Al-Ghanim (Qatar), Sergey N. Bobylev (Russian Federation), Opha Pauline Dube, (Botswana), Ibrahima Hathie (Senegal), Norichika Kanie (Japan), Nyovani Janet Madise (Malawi), Shirin Malekpour (Australia), J. Jaime Miranda (Peru), Jaime C Montoya (Philippines), Jiahua Pan (China), Åsa Persson (Sweden), Ambuj D Sagar (India), Imme Scholz (Germany), Nancy Shackell (Canada).
Led by Dr. Agard and Dr. Scholz, the independent group will author the second report of its kind. The first GSDR has been released in September of 2019 entitled “The Future is Now: Science for Achieving Sustainable Development.”
As the country’s lead coordinator for health research and development initiatives, PCHRD supports Filipino researchers in health research innovation, policy recommendations, and technology commercialization, provides scholarships to Filipino students in the field of health and medicine, and establishes information and communication systems to disseminate health research information both for local and international stakeholders. PCHRD is also at the forefront of the country’s fight against the current COVID-19 pandemic.
Filipino experiments revealed evidence that virgin coconut oil may be a means to defeat COVID-19.
“There are still alternative solutions against COVID-19 aside from vaccines. Although further investigation is needed before we develop a possible prevention or treatment option, we aim to give Filipinos hope through our ongoing local research initiatives,” said Department of Science and Technology Secretary Fortunato de la Peña.
After six months of experiments, results showed that compounds from coconut oil and virgin coconut oil, or VCO, a readily available commodity in the Philippines, decreased coronavirus count by 60-90% at low viral load.

Researchers also discovered that said compounds were observed to improve cell survival. More experiments, however, are needed to determine whether higher concentrations of these compounds will further reduce the replication rate of the virus.
"The results are very promising, as not only does it show that the VCO, by itself, can destroy the virus, but it also has a key mechanism in upregulating the immune response against COVID-19. Indeed, we look forward to the results of clinical trials on the various uses of VCO as an adjunct for the treatment of COVID-19," said Dr. Jaime C. Montoya, Executive Director of the Philippine Council for Health Research and Development (PCHRD).
Funded by the DOST-PCHRD, the research led by Dr. Fabian Dayrit of Ateneo De Manila University sought to investigate if coconut oil compounds are effective antiviral agents to prevent or reduce COVID-19 infection, following reports of previous research that VCO compounds are effective at killing other viruses.
With the lack of available vaccine for COVID-19, DOST seeks to intensify the thrust for alternative solutions to the increasing cases of COVID-19 by all means supporting Filipino research and innovations. Currently, the DOST, together with the Food and Nutrition Research Institute and the University of the Philippines - Manila, is already exploring the capability of VCO to upregulate the immune system. Results from these ongoing VCO Clinical trials will determine whether VCO can be used as adjunct therapy for COVID-19 patients.
Aside from facilitating the eventual conduct of the WHO vaccine clinical trials in the Philippines, the DOST-PCHRD is also supporting projects under its initiatives on Repurposing of Existing Drugs, Supplements and other Formulations, and Clinical Trials of Candidate Drugs to find viable treatment options against COVID-19.